(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 33.83% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 287.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.73%.
Fortress Biotech's revenue in 2025 is $62,303,000.On average, 4 Wall Street analysts forecast FBIO's revenue for 2025 to be $2,321,885,991, with the lowest FBIO revenue forecast at $2,007,006,120, and the highest FBIO revenue forecast at $2,629,999,592. On average, 4 Wall Street analysts forecast FBIO's revenue for 2026 to be $3,467,558,322, with the lowest FBIO revenue forecast at $3,292,814,736, and the highest FBIO revenue forecast at $3,610,953,591.
In 2027, FBIO is forecast to generate $4,600,132,643 in revenue, with the lowest revenue forecast at $4,419,491,849 and the highest revenue forecast at $4,735,458,048.